Peter G Rose (Peter Rose)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Cancer Stem Cells

Top Venues

JCO precision oncology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Mansoor R Mirza, Antonio González-Martín, Whitney S Graybill, David M O'Malley, Lydia Gaba, Oi Wah Stephanie Yap, Eva M Guerra, Peter G Rose, Jean-François Baurain, Sharad A Ghamande, Hannelore Denys, Emily Prendergast, Carmela Pisano, Philippe Follana, Klaus Baumann, Paula M Calvert, Jacob Korach, Yong Li, Izabela A Malinowska, Divya Gupta, Bradley J Monk
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Cancer (2023)
Peter G Rose, Johanna A Kelley, Myra Feldman, Kevin Krivanek
Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial Cancer. JCO precision oncology 7 (2023)
Laura Moulton Chambers, Emily E Rhoades, Rashmi Bharti, Chad Braley, Surabhi Tewari, Lexie Trestan, Zahraa Alali, Defne Bayik, Justin D Lathia, Naseer Sangwan, Peter Bazeley, Amy S Joehlin-Price, Zeneng Wang, Sumita Dutta, Mohammed Dwidar, Adeline M Hajjar, Philip P Ahern, Jan Claesen, Peter G Rose, Roberto Vargas, Jonathan Mark Brown, Chad M Michener, Ofer Reizes
Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer. Cancer research (2022)